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I-A and I-E gene products of the murine histocompatibility complex (H-2) are 
expressed by most B cells and to varying degrees by macrophages and T  cells (1, 
2). I-J products are intimately involved in immune regulation and are expressed 
by Ts cells and their factors (TsF), 1 as well as by some Th cells and macrophages 
(3, 4).  A great deal is known about the function, serology, and biochemistry of 
the  I-A and  I-E molecules, due in part,  to a  large  number  of cells expressing 
these  molecules  in  high  density  on  their  cell  membranes.  The  paucity  of I-J 
products has limited their characterization  mainly to functional studies (3, 5). 
I-J-bearing TsF have been shown in several antigen systems, including  KLH 
(6), Ars (7), GAT (8), and poly(GluS°Tyr  ~°) (GT) (9). Moreover, in the KLH and 
Ars systems, I-J identity between the TsF donor and recipient  is required  for 
suppression (7,  10). No such restriction pattern has been shown for the GAT- or 
GT-TsF1  (first-order suppressor factor) (8,  1 1,  12).  Sorensen and  Pierce (13), 
however, reported an I-J-restricted GAT-TsF2 derived from responder mice. In 
the GT system, there is not a complete lack of allogenic restriction (1 1). Injection 
of  H-2  b'd'k haplotype  mice  with  GT  produces  GT-TsF1  that  suppress  PFC 
responses  of H-2  a'd'k mice  to  the  immunogenic  form  of GT,  GTMBSA  (GT 
coupled to methylated bovine serum albumin [MBSA]) (1 1, 12). H-2  b'q's haplotype 
mice are not suppressed by GT-TsF1 (reference 1 1 and this paper). 
The  present study shows that  I-E molecules must be expressed in order for 
the recipient strain to be suppressed by I-J-bearing GT-TsF 1. We show that GT- 
TsF 1 is presented in the context of I-E molecules and that GT-TsF 1 presentation 
is blocked by anti-I-E, but not anti-I-A, antibodies.  Our results indicate recog- 
nition between I-J and I-E molecules. 
Materials and Methods 
Mice.  AKR/Cum (H-2 k) and BALB/cCum (H-2  a) mice were purchased from Cumber- 
land View Farms,  Clinton,  TN. C57BL/6J (B6; H-2b), BI 0.BR (H-2k), A.SW (H-2~), and 
SJL/J (H-2  ~) were obtained from The Jackson Laboratory, Bar Harbor, ME. D2.GD (H- 
2g~), A.TRF5 (H-2aPS),  and (D2.GD × A.TRF5)F1 hybrid mice were the generous gifts of 
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Dr. Chella David,  Mayo Clinic,  Rochester, MN. B10.A(4R) (4R; H-2h4), B10.A(5R) (5R; 
H-2i5), CBA/JNCr (H-2d), and BALB/cNCr (H-2  a) mice were obtained from the Animal 
Genetics and Production Branch of the National Cancer Institute, Frederick, MD. Female 
mice,  2-4 mo old, were used throughout and maintained on standard laboratory chow 
and water ad lib. 
Antigens  and Immunizations.  GT, 39,000 D, (lot  No. 51F5054) and GAT 25,000 D, 
(lot No. 51 F5040) were purchased from Sigma Chemical Co., St. Louis,  MO. MBSA was 
prepared  by the  method of Sueoka and  Cheng (14).  Antigen solutions and GTMBSA 
were prepared as previously described (12). For in vivo studies described in Tables II and 
III, BALB/c and  4R  mice  were  immunized  with  20  #g GT as  GTMBSA  in  Maalox 
(aluminum-magnesium hydroxide gel,  Wm.  H.  Rorer,  Inc.,  Ft.  Washington,  PA) and 
Bordetella pertussis intraperitoneally as adjuvant. 
GT-TsF Preparation.  BALB/c (I-Ja), B10.BR (l-jk), and B6 (I-J  b) GT-TsF1  were pre- 
pared as described (11). Briefly,  mice were injected intraperitoneally with  100 #g GT in 
Maalox.  3 d after injection, 6 ×  108 spleen cells/ml in HBSS were sonicated as previously 
described (11). Sonicated material was centrifuged at 40,000 × g for 45 min at 4°C. The 
GT-TsF 1  -containing supernatants were stored at -85 o  C until use. I-Jk-bearing monoclo- 
nal GT-TsF1 (WF11.3A1), GT-TsF2 (WF21.M5.A4), and GT-TsF3 (WF21.K3.Eg) have 
been described (15). Factors were used at concentrations indicated in the table legends. 
mAbs  and  Cell Lines.  B  cell  hybridomas secreting anti-I-E  k (17.3.3)  and  anti-I-E  k 
crossreactive with I-E  d (14-4-4S)  mAb were obtained from the Cell Distribution Center, 
Salk  Institute, La Jolla, CA. An anti-I-Ek-containing culture supernatant (Y-17) was the 
gift  of Dr.  Charles Janeway,  Yale  Medical  School,  New  Haven,  CT.  Anti-I-A  p mAb 
(6.5.2),  which crossreacts with  I-A  a, was the gift of Dr. J. Frelinger, University of North 
Carolina, Durham. The Ia  + BALB/c B cell lymphoma, A20-2J (16,  17), was the kind gift 
of Dr. A. Abbas, Harvard Medical  School, Boston, MA. 
GT-TsF and Antigen Presentation.  Exponentially growing A20-2J cells were harvested 
from DMEM  supplemented  with  10%  FCS  and washed twice  with  HBSS.  To prohibit 
A20-2J cell division,  107 cells were treated with 3.7 ×  10  -5 M mitomycin C in 1 ml DMEM 
at  37°C  for 30  min.  The  cells  were  then  washed  three  times  in  HBSS.  Under these 
conditions,  A20-2J  cells  showed  no  growth  after  7  d  of culture.  Where  indicated, 
mitomycin C-treated A20-2J cells were incubated with a  1:200 final dilution of anti-I-A  a 
or anti-I-E  d mAb for 20 min at 4°C, then washed three times with HBSS.  100 #g of GAT 
in  1 ml  or a  1:200  final  dilution  of monoclonal GT-TsF1  (WFll.3A1)  in  1  ml  was 
incubated with  107 A20-2J cells in DMEM containing 10% FCS for 30 min at 37°C in a 
humidified atmosphere of 5%  CO2  in  air.  Cells  were washed  three  times  with  HBSS, 
counted, and added in numbers indicated to BALB/c spleen cultures. 
Spleen Cell Culture and Hemolytic Plaque Assay.  Single-cell suspensions  of BALB/cCum 
(H-2  d)  spleen  cells  were  placed  in  modified  Mishell-Dutton  type culture  conditions as 
described (15). mAb, GT-TsF, or treated A20-2J cells were added at culture initiation in 
concentrations/numbers indicated  in  table  legends.  Cultures were  harvested  5  d  after 
initiation,  cells washed three times in HBSS, and PFC responses were assayed using SRBC 
coupled with the crossreacting polymer GAT as previously described (18). PFC responses 
from in vivo primed BALB/c and 4R mice (Table III) were determined 7 d after GTMBSA 
immunization. 
Results 
Role of l-E Gene Products  on  GT-TsF1  Suppression.  GT-TsF1  suppresses  the 
GTMBSA PFC responses of several inbred mouse strains, although no correlation 
between  suppression  and  a  particular  allele  within  H-2  has  been  shown  (11). 
Table I  summarizes the suppression patterns for five different H-2 haplotypes. 
H-2  a""ak mice are suppressed by GT injection, and produce and are suppressed 
by  GT-TsF1.  H-2  b  mice  produce  GT-TsF1,  but  are  not  suppressed  by  GT 
preimmunization  or  GT-TsF1.  Conversely,  H-2  a mice  are  suppressed  by GT- WALTENBAUGH  ET  AL. 
TABLE  I 
Strains Suppressed by GT-TsF I 
799 
Strain 
H-2 
K  A  J  E  C  S  D 
GTMBSA 
responses 
Produces  suppressed 
GT-TsF1  by: 
GT  GT-TsF 1 
BALB/c 
BI0.D2 
DSA/2 
B10.BR 
AKR 
CBA/J 
d  d  d  d  d  d  d  Yes  Yes  Yes 
k  k  k  k  k  k  k  Yes  Yes  Yes 
B 10  b  b  b  (b)  b  b  b  Yes 
B6, A.BY 
A/J  k  k  k  k  d  d  d  No 
B10.A 
(B10 ×  B10.A)F1  k  k  k  k  d  d  d  Yes 
b  b  b  (b)  b  b  b 
DBA/1  q  q  q  (q)  q  q  q  No 
No  No 
No  Yes 
Yes  Yes 
No  No 
This table summarizes previously published data (11, 12, 26, 27). (), silent alleles. 
TsF1, although they lack the ability to produce this factor. H-2  axb hybrid mice 
are suppressed by GT preimmunization, and produce and are suppressed by GT- 
TsF1.  GTMBSA  responses of H-2  q cannot  be  suppressed.  Although  this  is  a 
limited sampling,  it is striking  that  mice expressing  I-E molecules (H-2  a'u'k and 
H-2  "xb) are suppressed by GT-TsF1  and those not expressing surface I-E mole- 
cules (H-2 b'q) are not suppressed. 
H-2  s haplotype mice do not express I-E molecules (19). However, GT injection 
markedly  diminishes  the  GTMBSA responses of SJL,  A.SW,  and  B10.S mice 
(20,  21).  The  protocol  of GT  injection  followed by GTMBSA  immunization 
measures tolerance-type induction and does not address the role of suppressor 
factors. Are H-2  ~ mice suppressed by GT-TsFI? Table II shows that neither SJL 
nor A.SW mice are  suppressed by BALB/c GT-TsF1  (Exp.  1) and that  SJL is 
not suppressed by B10.BR GT-TsF1  (Exp.  2).  Therefore,  it appears that  H-2  s 
mice are not susceptible to GT-TsFl-mediated  suppression.  GT injection  may 
induce tolerance rather  than  suppression in H-2  ~ mice. H-2  b mice express I-A  b 
but not  I-E,  B10.A(3R) and  B10.A(5R) mice express both  I-A  b and  I-E  k (19). 
Table  II,  Exp.  3,  shows  that  5R  mice  are  readily  suppressed  by  GT-TsF1. 
Although not shown,  3R mice show a  similar result.  I-A  b has no adverse affect 
on GT-TsF 1 susceptibility and, again, we see concordance of I-E expression and 
GT-TsF1  suppression. 
Is the  I-E  requirement  qualitative  or  quantitative?  A.TFR5  (H-2  apS, E~,  E~) 800  1-E  RECOGNITION  BY  I-J  MOLECULES 
TABLE  II 
GT-TsF1 Suppresses B10.A(SR) (H-215) But Not H-2" Mice 
Number 
Strain  of mice  Factor*  GT-specific PFC  p value~ 
per group  per spleen* 
Experiment I 
BALB/c (H-2  d)  6  BALB/c Maalox  7,995 ±  1,531 
6  BALB/c GT-TsF1  470 ± 201  <0.001 
SJL (H-2  s)  11  BALB/c Maalox  8,342 ± 819 
11  BALB/c GT-TsF1  8,286 ±  1,066  0.96 
A.SW (H-2  s)  8  BALB/c Maalox  7,800 ±  1,748 
7  BALB/c GT-TsF1  4,910 ±  1,261  0.12 
Experiment 11 
BI 0.BR (H-2  k) 
SJL (H-2') 
Experiment Ill 
AKR/Cum (H-2  k) 
B10.A(5R)  (H-2  ~) 
3  B10.BR Maalox  6,412 +  1,537 
2  B10.BR GT-TsF1  175 ± 35  0.04 
5  B10.BR Maalox  3,420 ±  1,168 
5  B10.BR GT-TsF1  3,760 ±  1,720  0.87 
4  None  9,425 ±  1,096 
4  Monoclonal GT-TsF1  5,475 ± 825  0.029 
4  None  10,350 ± 676 
4  Monoclonal GT-TsF1  5,075 ± 863  0.003 
* Mice were injected intr~avenously with  0.5  ml of a control (Maalox) or GT-TsF1 containing cell- 
free extract (1.5  ×  107 cell equivalents)  or with  a  culture supernatant (WF11.3A1)  containing 
monoclonal GT-TsF1  (1:20  final dilution).  Mice were immunized intraperitoneally immediately 
thereafter with  10 t~g GT as GTMBSA in Maalox-pertussis  as adjuvant. 
* 7 d after GTMBSA immunization, GT-specific PFC per spleen were counted. Numbers represent 
arithmetic mean + standard error of the mean. Underlining indicates  suppression. 
The F-distribution  statistic  was  used  to  test  significance  in  analysis  of variance  (ANOVA)  in 
comparing GT-TsF1 injected animals with appropriate control mice. 
mice express membrane  I-E at low density levels, 80+%  less than  "normal" mice 
(22).  This  is most  likely due  to  the fact  that  E~ is not  expressed,  although  E~ is 
expressed (22). (A.TRF5  ×  D2.GD)F1  hybrid mice express I-E surface molecules. 
Does this correlate  with GT-specific suppression?  The  GTMBSA  PFC responses 
of (A.TRF5  x  D2.GD)F1  hybrids  are  suppressed  by  GT  preimmunization,  by 
B6 (I-J  b) GT-TsF1,  BALB/c  (I-J  d) GT-TsF1,  and  B10.BR  (I-J  k) GT-TsF1  (Table 
III). In contrast,  parental  strains D2.GD and A.TFR5  are not suppressed  by GT 
or  GT-TsF1  injection.  These  data  suggest  that  GT-TsF1  suppression  requires 
expression  of an  Ee gene  product  and/or  that  the  density  of I-E expression  is 
important. 
Suppressor  Defect in BIO.A(4R) Mice.  Araneo  and  Kapp (23)  showed suppres- 
sion of T  cell proliferative responses to GTMBSA  by GT-TsF.  With one notable 
exception,  their  proliferation  data  are  concordant  with  our  PFC  data.  Araneo 
and  Kapp  (23)  suppressed  proliferative  responses  of B10.A(4R)  to  GTMBSA 
using GT-TsF 1. T  cell proliferative,  delayed hypersensitivity,  and PFC responses 
are not always concordant,  indicating  the assay of different  cell populations  (24, 
25).  Can GTMBSA  PFC responses of 4R mice be suppressed? Table IV indicates 
that neither GT  nor BALB/c  (I-J  d) GT-TsFs  injection  is inhibitory to subsequent WALTENBAUGH ET  AL.  801 
TABLE  III 
I-E Gene Complementation  and GT-TsF1 Suppression 
1-Region*  GT-specific PFC per culture  ~ 
Strain  Control  GT +  B6 GT-  BALB/c  B10.BR 
Aa  A,,  Ea  Ea  GTMBSA  GTMBSA  TsF1  GT-TsF1  GT-TsF1 
D2.GD  d  d  d/b  (b)  t ,760  1,900  1,760  1,560  1,490 
A.TFR5  f  f  (f)  k  1,890  2,200  2,540  1,740  1,490 
(A.TFR5 X  f  f  (f)  k  950  60  ~  <15  260  60 
D2.GD)F1  d  d  d  (b)  --  -- 
* Assigned alleles for I-A and I-E loci are indicated. A recombinant event occurred in D2.GD strain 
within the E  a locus, hence this locus is partially composed of both E~ and E~ genetic material. (), 
silent alleles. 
~; D2.GD, A.TRF5, or (A.TRF5 x D2.GD)F1 spleen cells were placed in 5-d MishelI-Dutton cultures 
containing 2.5 tJg GT as GTMBSA. The cultures contained no additions (control),  10 ~g GT, or 
B6 (l-Jb), BALB/c (I-Jd), or BI 0.BR (I-J  k) GT-TsFl-containing  suppressor extracts  at  1:400 final 
concentration (1.5 ×  10  n cell equivalents). 
Underlining  indicates suppression. 
TABLE  IV 
Effect of GT-TsF1 or GT on the GTMBSA PFC Responses of BALB/c and 4R Mice 
Antigen* im-  GT-specific PFC/ 
No.  Treatment* given on  munized on  spleen  s measured  P value  !  Strain  Mice per  day 0 
Group  day 3  on day 10 
BALB/c  7  None  GTMBSA  9,200 + 910  -- 
8  BALB/c GT-TsFI  GTMBSA  2,470 + 720  <0.001 
4  GT  GTMBSA  2,480 + 2,130  0.007 
B10.A(4R)  11  None  GTMBSA  15,470 _  2,890  -- 
12  BALB/c GT-TsF1  GTMBSA  16,120 + 2,410  0.898 
7  GT  GTMBSA  10,540 4- 1,400  0.579 
* BALB/c and 4R mice were either injected with 0.5 ml BALB/c GT-TsF1 intravenously diluted 
1:5 in HBSS (1.2 x  107 cell equivalents), injected intraperitoneally  with 100 tLg GT in Maalox, or 
were uninjected. 
* 3 d after GT or BALB/c GT-TsF1 injection, the mice were immunized intraperitoneally  with 20 
t~g GT as GTMBSA in Maalox-pertussis as adjuvant. 
7 d after GTMBSA immunization  (day I 0) GT-specific PFC per spleen were enumerated. Numbers 
represent the arithmetic mean + standard error of the mean. Underlining  indicates suppression. 
The F-distribution  statistic was used to test significance in analysis of variance (ANOVA) between 
experimental groups. 
GTMBSA  immunization. As  control,  the  GTMBSA  PFC  responses of GT  or 
GT-TsF1 injected mice are suppressed by >70%. 
Previously, we showed that H-2  b mice produce GT-TsF1  upon GT  injection, 
however they are unable to make second-order Ts (Ts2). Do 4R mice display a 
similar defect? GTMBSA  PFC responses of H-2  b mice are suppressed by factors 
that circumvent Ts2 (26,  27).  Hence, H-2  b mice are suppressed by monoclonal 
I-J  ~  GT-TsF2  and  I-J  k  GT-TsF3,  but  not  by  monoclonal  I-J  k  GT-TsF1.  To 
ascertain the cellular defect, monoclonal TsF were injected into 4R mice. Neither 
GT-TsF1  nor GT-TsF2  suppresses GTMBSA  PFC responses of 4R spleen cell 
cultures, although these factors specifically suppress BALB/c spleen cell cultures 
(Table V).  Monoclonal GT-TsF3  suppresses  the  4R  GTMBSA  PFC  response, 
which suggests that 4R mice have a  Ts3 defect. 802  I-E  RECOGNITION  BY  I-J  MOLECULES 
TABLE  V 
Effect of GT-TsF1,2,3 on the GTMBSA PFC Responses of  B IO.A(4R) and BALB/c Spleen 
Cells in Vitro 
GT-specific  Percent 
Strain  Hybridoma factor  Type of factor'*  PFC per  GTMBSA 
source*  culture0  response  t 
B10.A(4R)  None  --  775  -- 
WF11.3A1  TsF1  820  106 
WF21 .M5.A4  TsF2  1,160  150 
WF21 .K3.E9  TsF3  60  8 
BALB/c  None  --  850  -- 
WF11.3A1  TsF1  <20  2 
WF21.M5.A4  TsF2  <20  2 
WF21.K3.E9  TsF3  <20  2 
* Supernatants,  each containing a different I-J  k GT-specific suppressor factor, were added at  1:400 
final dilution at culture initiation. All Mishell-Dutton cultures contained 2.5 gg GT as GTMBSA. 
* Nominal factor designation based upon kinetics of suppression (15). 
5 d after culture initiation, GT-specific responses were assayed. Underlining indicates suppression. 
Relationship of control GTMBSA culture (not receiving factor) to factor containing culture. 
Demonstration  of the Requirement for I-E Molecules Using mAbs.  Strains of mice 
not expressing I-E are not suppressed by GT-TsF 1 (Tables I-III and references 
11, 26, 27),  implying, but not proving, that I-E expression is essential for factor- 
mediated suppression. This suggests that GT-TsF1  is presented by MHC class 
II-bearing cells and/or that GT-TsF1 recognizes (or is recognized in the context 
of)  I-E  molecules.  To resolve these  possibilities,  we  asked  whether GT-TsF1 
suppressive activity can be absorbed by normal spleen cells. Table VI shows that 
the  suppressive  activity of monoclonal GT-TsF1  (WF11.3A1)  is  absorbed  by 
AKR/Cum spleen cells  at 4 °C. If AKR/Cum (H-2  k) spleen cells  are incubated 
with monoclonal anti-I-E  k (17-3-3)  at 4°C,  before incubation with GT-TsF1, 
then  they  no  longer  absorb  suppressor  activity  (Table  VI).  Incubation  of 
AKR/Cum spleen cells with a supernatant derived from the secretory P3X63Ag8 
(P3)  myeloma does  not  inhibit  the  ability of these  cells  to  absorb  GT-TsF1 
activity. Although not shown, an immunoadsorbent column constructed with 
this same anti-I-E  k mAb (17-3-3)  does not bind  I-J  k GT-TsF1;  therefore, the 
effect of 17-3-3  is directed not against the factor, but toward the target cell of 
the factor. Direct addition of anti-I-E  k mAb (17-3-3)  to AKR/Cum spleen cell 
cultures blocks GT-TsFl-mediated suppression (Table VII). Addition of either 
17-3-3 or Y-17  anti-I-E  k mAb blocks suppression mediated by either I-J  k GT- 
TsF1  (WF1 1.3A1) or I-J  d BALB/c GT-TsF1, while neither antibody adversely 
affects the GTMBSA PFC response of CBA]J (H-2 k) spleen cell cultures. These 
data lend support for the notion that anti-I-E  k mAb blocks factor presentation 
and that the antibody is not directed against the factor. 
Cellular Presentation  of GT-TsF1.  Our data implicate I-E, and hence APCs, in 
GT suppression. We would predict that I-E-bearing cells  should function in a 
factor-presenting  capacity.  To  test  this  hypothesis,  we  used  the  Ia-bearing 
BALB/c lymphoma cell line A20-2J.  Between  102  tO  104  mitomycin C-treated 
A20-2J cells were added to BALB/c spleen cell Mishetl-Dutton cultures. Mito- WALTENBAUGH ET  AL.  803 
TABLE VI 
Absorption and Blocking of GT-TSFI by 17-3-3 in BALB/c and AKR/Cum 
Spleen Cells Cultures 
Strain 
GT-spe- 
Monoclonal  cific PFC 
factor*  Treatment*  Antigen§  per cul- 
ture m 
BALB/c  None  None  GTMBSA  915 
WF11.3A1  None  GTMBSA  <30 
WF11.3AI  Factor absorbed on AKR/Cum spleen  GTMBSA  830 
cells 
WF11.3A1  Factor absorbed with 17-3-3-blocked  GTMBSA  <30 
AKR spleen cells 
AKR/Cum  None  None  GTMBSA  1,010 
WF11.3Al  None  GTMBSA  <20 
WF11.3A1  Factor absorbed with sham-blocked  GTMBSA  1,155 
AKR spleen cells 
WF11.3A1  Factor absorbed with 17-3-3-blocked  GTMBSA  <20 
AKR spleen cells 
* (Un)absorbed culture supernatant containing I-J  k monoclonal GT-TsF 1 (WF 11.3A  1) was added at 
1:500 final dilution at culture initiation. 
* Where indicated above, normal  AKR/Cum (107) spleen cells were incubated with 1.0  ml  of 
supernatant from the P3X63Ag8 myeloma (sham) or with 1.0 ml anti-I-Ek-containing  supernatant 
from the 17-3-3 hybridoma for 20 rain at 4°C. The (un)absorbed cells were washed three times in 
HBSS and the pellet resuspended to 1.0 ml with a culture supernatant containing monoclonal GT- 
TsF1 (WFI 1.3A1) diluted 1:50 and incubated for 30 min at 4°C. The AKR/Cum spleen cells were 
removed by centrifugation and the WF 11.3A 1 supernatants were added to MishelI-Dutton cultures 
at 1:500  final dilution (10% by vol). 
At initiation all cultures received 1.25 #g GT as GTMBSA as immunogen. 
I 5 d after culture initiation, GT-specific  responses were assayed. Underlining indicates suppression. 
mycin C blocked cellular division of the A20-2J cells. Addition of unpulsed A20- 
2J cells along with GTMBSA had no inhibitory effect upon the GT-specific PFC 
response of BALB/c spleen cells (Table VIII). A20-2J cells were incubated with 
monoclonal GT-TsF1  (WF11.3A1) for 15 min at 4°C, washed four times,  then 
added to BALB/c spleen cell cultures.  Table VIII shows that  104 or  103 factor- 
pulsed spleen cells suppress the GTMBSA response.  102 to 104 GAT-pulsed A20- 
2J present GAT to BALB/c spleen cell cultures. 
Blocking of Factor Presentation by mAbs.  The involvement of I-E molecules in 
factor presentation is demonstrated by the blocking of A20-2J factor presentation 
by mAb. Direct addition ofGT-TsF 1 (WF 11.3A 1) to BALB/c spleen cells inhibits 
the  GTMBSA response  (Table  IX).  Unpulsed  A20-2J cells are  not  inhibitory. 
WF11.3Al-pulsed A20-2J cells inhibit the GT-specific PFC response. Incubation 
with  anti-I-E  d mAb before  factor pulsing blocks the  ability of A20-2J cells  to 
present GT-TsF 1. The blocking of A20-2J factor presentation by anti-I-E  d mAb 
is  most likely not due  to  steric  hinderance,  as  anti-I-A  ~ does not block factor 
presentation.  Conversely, anti-I-A  ~,  but  not anti-I-E  ~,  mAb blocks GAT pres- 
entation by A20-2J. This serves as a  negative control for anti-I-E  d mAb and a 
positive control for anti-I-A  d. Although not shown, mAb treatment of unpulsed 
A20-2J cells has no inhibitory effect upon the GTMBSA responses of BALB/c 804  I-E  RECOGNITION  BY  l-J  MOLECULES 
TABLE  VII 
Effect of anti-I-E  k mAbs on GT-TsF1 Activity in AKR/Cura and CBA/J Spleen Cell Cultures 
Anti-l-E  k  GT-specific 
Strain  GT-TsF1 added*  added to cul-  Antigen§  PFC per cul- 
ture~:  ture I 
AKR/Cum  None  None  GTMBSA  1,170 
None  17-3-3  GTMBSA  1,460 
WF11.3A1  None  GTMBSA  <25 
WF11.3A1  17-3-3  GTMBSA  1,290 
CBA/J  None  None  GTMBSA  1,560 
None  17-3-3  GTMBSA  1,200 
None  Y- 17  GTMBSA  2,110 
WF11.3A1  None  GTMBSA  <25 
WF 11.3A 1  17-3-3  GTMBSA  1,510 
WF11.3A1  Y-17  GTMBSA  1,575 
BALB/c GT-TsF 1  None  GTMBSA  <25 
BALB/c GT-TsFI  Y-17  GTMBSA  1,425 
* Monoclonal I-J  k GT-TsF1  (WF11.3A1) containing culture supernatants or a  BALB/c spleen cell 
extract containing I-J  d GT-TsF1  (6 ×  108 ceil equivalents/ml) were added at 1:400 final concentra- 
tion at culture initiation. 
* 10 t*l undiluted culture supernatants containing anti-I-E  k mAb were added at culture initiation. 
At initiation, cultures received 1.25 #g GT as GTMBSA. 
' After 5 d of culture, GT-specific responses were assayed. Underlining indicates suppression. 
TABLE  VIII 
Factor and GAT Presentation by A20-2J Cells in BALB/c Spleen Cell Cultures 
Mitomycin C-treated cells* 
Additions directly to culture*  GT-specific PFC 
Factor  Antigen  per culture  ~ 
None  None  GTMBSA  1,155 
None  WFI ! .3AI  GTMBSA  <20 
104 A20-2J +  --  None  GTMBSA  1,060 
10 s A20-2J +  --  None  GTMBSA  1,580 
102 A20-2J +  --  None  GTMBSA  1,240 
l04 A20-2J +  WF11.3A1 
l0  s A20-2J +  WFI 1.3A1 
102 A20-2J +  WF11.3A1 
None  GTMBSA  350 
None  GTMBSA  <20 
None  GTMBSA  1,030 
104 A20-2J +  GAT  None  None  1,330 
103 A20-2J +  GAT  None  None  1,325 
102 A20-2J +  GAT  None  None  1,060 
* Mitomycin  C-treated  A20-2J  B  lymphoma cells  were  either pulsed  with monoclonal  GT-TsF1 
(WF11.3A1),  GAT,  or  not pulsed (as control) and added at numbers indicated at initiation of 
MishelI-Dutton culture. 
* GTMBSA (1.25 t~g/culture) was added at culture initiation to indicated cultures. Some cultures 
were immunized by GAT-pulsed A20-2J cells and received no additional antigen. Monoclonal GT- 
TsF1 (WF11.3A1) was added (1:400 final concentration) at culture initiation to one culture. 
GT-specific responses were assayed 5 d after culture initiation. Underlining indicates suppression. 
spleen  cells,  Our  data  strongly  implicate  a  role  for  the  association  of GT-TsF1 
and  the  I-E surface  molecules  in the  presentation  of suppressor  activity. WALTENBAUGH  ET  AL. 
TABLE  IX 
Blocking of A20-2J Factor Presentation by Anti-I-E  k mAb 
805 
Mitomycin C, A20-2J cells*  Direct addition to culture  Antigen-spe- 
cific PFC per 
Antibody block-  Factor or antigen  Factor*  Antige  nl  culture! 
ing  pulsing 
--  --  --  GTMBSA  1,020 
--  --  WF11.3A1  GTMBSA  <20 
None  Unpulsed  --  GTMBSA  1,250 
None  WF11.3A1  --  GTMBSA  225 
Anti-I-E  a  WF11.3A1  --  GTMBSA  990 
Anti-l-A  a  WF 11.3A 1  --  GTMBSA  180 
--  --  --  GAT  340 
None  GAT  --  --  240 
Anti-l-E  d  GAT  --  --  330 
Anti-I-A  d  GAT  --  --  <20 
*  10 s mitomycin C-treated A20-2J cells were added to indicated cultures. Surface/-region  molecules 
were blocked with anti-l-E La (14-4-4S) or anti-l-A p'a (6.5.2) mAb as indicated above and described 
in  the  Materials and  Methods.  (Un)blocked  A20-2J cells were pulsed with either monoclonal  I-J  ~ 
GT-TsF1  (WF11.3A1),  GAT,  or unpulsed as indicated and added at culture initiation. 
* As indicated, monoclonal  I-J  k GT-TsF1  (WF11.3A1)  was added  directly to culture at  1:400 final 
concentration at culture initiation. 
0 At initiation, 1.25 ~tg GT  as GTMBSA,  5 ~tg GAT,  or no antigen additions were made to cultures. 
! After 5  d  culture, GT- or GAT-specific responses were assayed. Underlining indicates suppression. 
Discussion 
GT  is  unique  in  that  it  fails  to  induce humoral  or  cell-mediated immune 
responses  in  most  inbred  strains  of mice  (24,  25).  GT  injection  of H-2  b'd'k 
haplotype mice results in the production of an I-J-bearing TsF (GT-TsF1) that 
suppresses GTMBSA responses of H-2  "'d'k haplotype mice. In the present study, 
we show that GT-TsF1  function is restricted by I-E molecule expression in the 
recipient strain.  In contrast,  I-E expression does not appear to influence GT- 
TsF1  production; I-E-negative mice (e.g., H-2  b) can make GT-TsF1  (26,  27). 
GT-TsF1  suppresses susceptible strains regardless of haplotype (e.g., I-J  k, GT- 
TsF1 suppresses H-2", I-J  k, H-2  a, I-jd; and H-2 k, I-J  k mice) so long as the recipient 
strain expresses I-E molecules. Those strains unable to express I-E molecules are 
not  suppressed  by  GT-TsF1.  Therefore,  I-E  expression  by  the  recipient  is 
required for factor-mediated suppression.  This observation suggests a  role for 
MHC class  II molecules (e.g., I-E) and implies the role of class II-bearing cells 
or APCs in the presentation of factor. Indeed, we find an association between I- 
E molecules and GT-TsF 1 presentation. Normal spleen cells or the Ia  + cell line, 
A20-2J,  present  GT-TsF!  to  normal  syngeneic spleen  cells  in  vitro.  Factor 
presentation is specifically blocked by anti-I-E mAb. In contrast, anti-I-A, but 
not anti-I-E,  mAb blocks presentation of the I-A-restricted antigen GAT by 
A20-2J cells. This reciprocal experiment serves as a control for both GT-TsF1 
and GAT presentation, and rules out nonspecific steric hindrance by mAb as the 
reason for lack of factor presentation by I-E-blocked A20-2J cells. Although at 
this juncture it  is  impossible  to  establish  that  I-J + GT-TsF1  recognizes (or is 
recognized by) I-E molecules, our data point in this direction. 
Araneo and Kapp (23) found no MHC restriction between donors and recipi- 806  I-E  RECOGNITION  BY  l-J  MOLECULES 
ents of GT-TsF in the suppression of T  cell proliferative responses to GTMBSA. 
Our data are concordant with theirs with one notable exception and, therefore, 
we come to a different conclusion. Araneo and Kapp (23) showed the GT-specific 
T  cell proliferative responses of GTMBSA-primed  B10.A(4R) mice were sup- 
pressed  by GT-TsF  derived  from  H-2  a  mice.  We are  unable  to  demonstrate 
suppression of the PFC responses of 4R mice either in vivo with H-2  a (I-J  a) GT- 
TsF1 (Table IV) or in vitro with I-J  k GT-TsF1  (Table V). This disparity between 
T  cell proliferation and PFC data is probably best explained by the fact that each 
assay measures different cell populations. Recently, we have shown (24, 25) that 
T  cell proliferative, delayed hypersensitivity and  PFC responses are not always 
concordant, when assigning immune response (It)  gene responder status in the 
GAT and GT copolymer system. 4R mice do not express I-E surface molecules 
and GT-TsF1  does not suppress their  GTMBSA PFC response.  This is not to 
say that 4R mice cannot be suppressed by any GT-specific factor. GT suppression 
results from a cascade of suppressive events involving several distinct suppressor 
cells and their factors (12). Neither monoclonal GT-TsF 1 nor GT-TsF2 suppress 
4R mice, indicating  a  lack of suitable cellular  target for these factors.  On the 
other hand,  monoclonal  GT-TsF3  suppresses the GTMBSA PFC responses of 
4R mice (Table V) showing a functional target cell for TsF3. It is possible that 
the factor-containing extract used by Araneo and Kapp (23) may have contained 
sufficient GT-TsF3 to suppress the T  cell proliferative responses of 4R mice. 
In the present study, we find that GT-TsFI is restricted to recipients expressing 
I-E,  and  A.SW  and  SJL  mice  that  do  not  express  surface  I-E  (19),  are  not 
suppressed by GT-TsF1  (Table II). 5R mice, unlike parental B10 mice, express 
I-E,  and  are  suppressed  by GT-TsF1.  Possible interference  in  the  suppressive 
process by I-A  b is ruled out, because B6, B10, A.BY (nonsuppressible), and 5R 
(suppressible) mice all express I-A  b. A.TFR5  mice, which express low levels of 
E~, are not suppressed by GT-TsF 1 (Table III). This raises the exciting possibility 
that either the surface I-E requirement for GT-TsF 1 susceptibility is quantitative 
and A.TFR5 expresses too little, or that the I-E restriction requires expression 
of the  E~  gene.  Our  laboratory  is  currently  addressing  this  question.  Indeed, 
ours is not the  first laboratory to show the role of MHC class II molecules in 
suppressor systems. Dorf and co-workers (28, 29) showed the involvement of I- 
A-bearing APCs in Tsl  and Ts3  induction.  They suggest that the presence of 
I-A  on  cells  responsible  to  Ts  induction  does  not  necessarily  imply  a  direct 
involvement of I-A in the Ts induction  process (30). Further,  they suggest that 
Ia antigens  are  somehow involved in  the  induction  of I-J  determinants.  Nagy 
and colleagues (3 I) were the first to report a role for I-E in suppression of the T 
cell response, and that mouse strains expressing I-E  k are nonresponders to lactate 
dehydrogenase B. Nonresponsiveness is mediated by E~-specific  Ts (31) and an 
Ec-specific TsF (32). Our present data using GT-TsF1 are consistent with the E~ 
restriction. 
Originally,  the I-J subregion was defined and mapped by Murphy et al. (5) to 
a segment of the  17th chromosome of the murine MHC between the I-A and I- 
E subregions.  Steinmetz and co-workers (33, 34) found that this portion of the 
17th chromosome contained <3.4 kb DNA available for the I-J subregion, which 
is generally  considered  insufficient  to encode for a  single  molecule >_20 kDa. WALTENBAUGH ET AL.  807 
Nevertheless,  several  laboratories  have  reported  I-J  heterogeneity and  their 
selective expression  on  different cellular (sub)sets.  Anti-I-J  k mAb detects  I-J 
epitopes which are selectively expressed by different monoclonal TsF and have 
been used to phenotypically distinguish Ts subsets (15, 35, 36). Evidence for the 
expression of I-J expression by T  cells other Ts has been reported. Tada and 
Hayakawa (10) showed that some Th cells express I-J determinants distinct from 
those found on Ts. Gershon et al. (37) described contrasuppressor T  (Tcs) cells 
that  are suppressor antagonists  and express  unique  I-J determinants.  Nieder- 
huber et al. (38), using alioantisera, found I-J determinants on APCs. Murphy et 
al. (4), using alloantisera, showed I-J (J2) determinants expressed by macrophages 
to be distinct Ts I-J (J1) determinants. Likewise, Nakamura et al. (39) and Dorf 
and  co-workers (40)  have reported  the requirement for I-J-bearing APCs  in 
suppressor systems. 
What  is  "I-J"?  Tada  (41)  proposed  that  I-J  molecules are  self-recognition 
structures on T  cells that recognize self MHC class  II (i.e., I-E) molecules. Our 
data  agree  with  this  hypothesis.  To  a  large  extent  much  of the  confusion 
surrounding I-J appears  to  be a  matter of nomenclature. We propose that I-J 
structures are expressed only by T  cells and they recognize self class II determi- 
nants on  B  cells and  macrophages.  During ontogeny, T  cells develop a  self- 
recognition repertoire (I-J molecules) for self class II molecules. Tada (41) calls 
these self-recognition structures antetopes; Murphy et al. (4) called these deter- 
minants expressed on Ts, J~. Antibodies directed toward T  cell self-recognition 
structures are correctly called anti-I-J antibodies. Alloantisera can contain both 
anti-antetope (or anti-J0 antibodies (i.e., anti-I-J) and antibodies reactive with 
the Ia epitopes (Tada [41] calls these prototopes; Murphy et al. [4] calls these J2 
determinants) seen by the antetope. These anti-prototope antibodies should be 
reactive  with  class  II  MHC  molecules  found  on  B  cells  and  macrophages. 
Moreover, we would predict that anti-idiotype antibodies directed against anti- 
I-J (anti-antetope) mAb should react with class II epitopes. Anti-idiotype antisera 
directed against either anti-I-J  k (WF8.C12.8)  or anti-I-J  d (WF18.2B15)  mAb 
bind B cells and macrophages (42).  This same anti-idiotype blocks GT-TsF1- 
mediated suppression, in a manner similar to that of the present report. There- 
fore, expression of I-J determinants on cells other than T  cells would appear to 
be artifactual. 
We conclude that I-J is not H-2 encoded, but H-2 (e.g., I-E) influenced. Lack 
of sufficient DNA in  the interval  between Ea to  E, to account for a  separate 
definable I-J locus (33, 34) would not be a problem in that I-J is not H-2 encoded. 
In  fact, the  MHC  influences expression of several non-MHC genes (43).  The 
MHC may influence the selective expression of non-MHC I-J genes, thus account- 
ing for the apparent allelic nature of I-J.  Still,  several problems remain.  First, 
how do B10.A(3R) and B10.A(5R) differ? Both appear to express identical I-E 
molecules in two-dimensional gels (44). Small conformational differences of the 
translated E~ polypeptide chain could account for the difference in self-recogni- 
tion  repertoire  between  3R  and  5R,  or  alternatively  there  is  strain-specific 
posttranslational  modification of I-E  molecules. Second,  if I-J  recognizes I-E, 
then how are I-J  b molecules produced in H-2  b haplotypes, since H-2 b mice do 
not appear to express Ea surface molecules (44)?  Possibly I-J  b is complementary 808  I-E  RECOGNITION BY  I-j  MOLECULES 
to  LA  b,  or  alternatively, a  few,  but  sufficient, E~  cytoplasmic molecules are 
expressed on the surfaces of B cells and macrophages to allow the development 
of a  I-J  b T  cell  repertoire.  This  can  be  addressed with  the  B6.C  bmlz (bm12) 
mutant mouse. This mutation affects the A~ locus and arose by gene conversion 
from the E~ locus (45).  If I-J  b structures are complementary to I-A  b molecules, 
then one would predict that the I-J  b repertoire of H-2  bml2 bml2 would be different 
from parental  H-2  b B6.  Finally, why haven't I-J  genes  been  identified? The 
mechanism for  generating diversity of the  antigen-recognition repertoire  of 
immunoglobulins and T  cell receptors results from gene rearrangement. It is 
this very rearrangement together with the expression on T  cells, but not B cells, 
that allowed the identification of T  cell receptor genes (46).  If, however,  I-J 
molecules are genomically encoded and not rearranged and/or expressed by a 
very small subset of T  cells, then our current technology may be unable to detect 
these genes. 
Summary 
Poly(GluS°Tyr  5°) (GT) is not immunogenic in most inbred mouse strains. GT 
injection produces an I-J-bearing, GT-specific T-cell-derived suppressor factor 
(GT-TsF1)  in  H-2  TM  haplotype mice.  GT-TsF1  generates  second-order sup- 
pressor T  cells (Ts2) in H-2  ~'a'k haplotype mice. Here, we show that in order for 
GT-TsF 1 to act, the recipient strain must express I-E molecules. This suggests 
that T  cells are not the primary target of GT-TsF 1. GT-TsF 1 can be presented 
by Ia  + A20-2J B lymphoma cells.  GT-TsF1 presentation is blocked by anti-I-E, 
but not by anti-I-A, mAb, whereas GAT presentation is blocked by anti-I-A, 
but not by anti-I-E, mAbs. These data suggest that I-J recognizes (or is recognized 
by)  I-E.  The  existence  and  role  of I-J  molecules  in  immune  regulation  are 
discussed in light of these data. 
Received  for publication 22 October 1985 and in revised  form 17 December 1985. 
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